BSEInsider Trading / SAST2d ago · 23 Sept 2026, 06:45 pm
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 we wish to inform you that, the trading window for dealing in the securities of the company will remain closed w.e.f. October 01, 2026 for the Quarter and Half year ended September 30, 2026.
Auro Laboratories Ltd · 530233
✦ AI Summary
Auro Laboratories Ltd has announced the closure of its trading window for dealing in securities from October 1, 2026, due to the consideration of unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Auro Laboratories Ltd - 530233 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
798ce3a0-2e85-4fbe-aeb5-61a7a0dda1d2.pdf
View document text
314, T. V. lndusstrial Estate, S.K. Ahire Marg,
Auro Laboratories Limited
Worli, Mumbai -400 030. India
Tel.:+ 91 22 6663 5456
Fax : +91 22 6663 5460
E-mail : auro@aurolabs.com
Web : www.aurolabs.com
Reg. Off. I Mfg. Unit:
K-56, M. I. D. C. Tarapur,
Dist. Palghar, Maharashtra -401506.
CIN No. L33125MH1989PLC051910
September 23, 2026
The Listing Department
BSE Limited
Phiroz Jeejeebhoy Towers
Dalal Street, Mumbai -400 001.
Scrip Code: 530233
Subject Intimation of Closure of Trading Window under SEBI (PIT) Regulations, 2015
Dear Sir/ Madam,
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to
ti.me, we wish to inform you that, the Trading Window for dealing in the securities of the
Company will remain closed for all Connected/ Designated Persons and their immediate
relatives w.e.f. October 01, 2026 for the purpose of consideration of Un-audited Financial
Results for the Quarter and half year ended September 30, 2026.
The Trading Window shall open 48 hours after the Un-audited Financial Results for the
Quarter and half year ended September 30, 2026, becomes generally available
Kindly take the same on record.
Thanking you
For Auro Laboratories Limited
Siddhartha Deorah
Whole-time Director
DIN: 00230796